Alto Neuroscience, Inc. (ANRO) ROE
- 2026-06-30: ROE -38.42%.
- 2026-03-31: ROE -30.53%.
- 2025-12-31: ROE -41.84%.
- 2025-09-30: ROE -55.81%.
Complete source-backed roe history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -38.42% |
| 2026-03-31 | -30.53% |
| 2025-12-31 | -41.84% |
| 2025-09-30 | -55.81% |
| 2025-06-30 | -52.55% |
| 2025-03-31 | -45.42% |
| 2024-12-31 | -40.56% |
| 2024-09-30 | -34.81% |
| 2024-06-30 | -27.70% |
| 2024-03-31 | -21.98% |
| 2023-12-31 | 50.65% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -41.84% |
| 2024-12-31 | -40.56% |
| 2023-12-31 | 50.65% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |